Wordlesstech2021-02-28T10:42:02+02:00

Approval for Alzheimer’s Drug

Jun 10, 2021|

The U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans.

Get the Newsletter

subscribe to wt

Archives

Go to Top